BiotechTube

Namodenoson + Placebo

Phase 3Recruiting
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hepatocellular Carcinoma

Conditions

Hepatocellular Carcinoma, Cirrhosis

Trial Timeline

Mar 15, 2023 → Oct 1, 2026

NCT ID
NCT05201404

About Namodenoson + Placebo

Namodenoson + Placebo is a phase 3 stage product being developed by Can Fite Biopharma for Hepatocellular Carcinoma. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05201404. Target conditions include Hepatocellular Carcinoma, Cirrhosis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT05201404Phase 3Recruiting
NCT04697810Phase 2Recruiting

Competing Products

20 competing products in Hepatocellular Carcinoma

See all competitors
ProductCompanyStageHype Score
CT-01 + EVEROLIMUSCaptor TherapeuticsPhase 1
25
ateganosine + CadonilimabMAIA BiotechnologyPhase 1
25
Ramucirumab + PlaceboEli LillyPhase 3
77
ERY974 + Tocilicumab + Atezolizumab + BevacizumabChugai PharmaceuticalPhase 1
33
Atezolizumab + Bevacizumab + TiragolumabChugai PharmaceuticalPhase 3
77
GC33(RO5137382) + SorafenibChugai PharmaceuticalPhase 1
33
CS-1008 2 mg/kg + Sorafenib + CS-1008 6/2 mg/kg + CS-1008 6/6 mg/kg + CS-1008 4 mg/kg + CS-1008 6 mg/kgDaiichi SankyoPhase 2
52
Tivantinib + PlaceboDaiichi SankyoPhase 3
77
OSI-906 + PlaceboAstellas PharmaPhase 2
52
Enzalutamide + PlaceboAstellas PharmaPhase 2
52
Enzalutamide + Enzalutamide with SorafenibAstellas PharmaPhase 1
33
Recombinant oncolytic virus M1, anti PD-1 antibody, ApatinibSun PharmaceuticalPhase 1
33
Irinotecan + Sonidegib + SorafenibSun PharmaceuticalPhase 2
52
mFOLFOX7 combined with Camrelizumab and apatinibSun PharmaceuticalPhase 2
52
camrelizumab& apatinibSun PharmaceuticalPhase 2
52
LenvatinibEisaiPre-clinical
23
Lenvatinib PillEisaiPhase 2
52
Sorafenib + SorafenibEisaiPhase 1/2
41
LenvatinibEisaiPhase 2
52
Lenvatinib + NivolumabEisaiPhase 2
52

Other Products from Can Fite Biopharma

CF101Phase 3
69
piclidenoson + PlaceboPhase 3
69
CF101 1 mg + CF101 2 mg + Placebo + MTXPhase 3
69
CF101 2mg + CF101 3mg + Apremilast 30mg + Placebo Oral TabletPhase 3
69
CF101 + PlaceboPhase 2/3
57